EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Short Interest Update

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOYGet Free Report) saw a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling 3,171 shares, an increase of 77.4% from the March 15th total of 1,787 shares. Based on an average daily trading volume, of 171,127 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are sold short.

EssilorLuxottica Price Performance

Shares of ESLOY stock opened at $116.43 on Tuesday. The company has a current ratio of 0.99, a quick ratio of 0.70 and a debt-to-equity ratio of 0.17. EssilorLuxottica has a 12 month low of $109.00 and a 12 month high of $186.81. The stock has a 50 day moving average of $128.21 and a 200-day moving average of $154.40.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. HSBC upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Wednesday, January 14th. Kepler Capital Markets upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Thursday, January 15th. Two research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Buy”.

Get Our Latest Analysis on ESLOY

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Featured Articles

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.